FMA
SPHS

FNY Managed Accounts’s Sophiris Bio, Inc. SPHS Stock Holding History

FNY Managed Accounts’s Portfolio SPHS Stock Details SPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-8,400
Closed -$26.1K – 421
2016
Q3 		$26.1K Buy
8,400
+844
+11% +$3.17K 0.02% 249
2016
Q2 		$16.2K Buy
+7,556
New +$10.4K 0.01% 180

Other funds holding SPHS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
SMV
Sofinnova Management VIII Menlo Park, California $183M AUM 4.18% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
AL
Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FNY Managed Accounts's SPHS Position: Q4 2016 in Review

FNY Managed Accounts sold out of Sophiris Bio, Inc. (SPHS) in Q4 2016, closing a stake of 8,400 shares — an estimated $26.1K sold.

FNY Managed Accounts first reported a position in SPHS in Q2 2016 and held it in 2 quarters. The position peaked at $26.1K in Q3 2016. 30 funds tracked by Wall St. Rank hold SPHS as of Q4 2016.

  • FNY Managed Accounts reported no remaining Sophiris Bio, Inc. position as of Q4 2016 after selling out during the quarter.
  • FNY Managed Accounts sold 8,400 Sophiris Bio, Inc. shares in Q4 2016, an estimated $26.1K.
  • FNY Managed Accounts first reported a position in Sophiris Bio, Inc. in Q2 2016 and held it in 2 quarters.
  • FNY Managed Accounts's Sophiris Bio, Inc. position peaked at $26.1K in Q3 2016.
  • 30 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q4 2016.

Based on FNY Managed Accounts's 13F filing for Q4 2016, filed 8 Feb 2017.